Thromboxane (Tx)B2 and 6-keto-prosta glandin (6-keto-PG) Flo< formation in the hippocampus and caudate nucleus were evaluated by microdialysis dur ing and following forebrain ischemia. Spontaneously hy pertensive rats were subjected to bilateral carotid artery occlusion with simultaneous hypotension for 8, 14, or 20 min. Dialysate was collected during the ischemic interval and during the reperfusion period. TxB2 and 6-keto PGFlo< levels were measured by radioimmunoassay. In both structures, TxBz production increased significantly during the reperfusion period in all three ischemic groups. By contrast, increased 6-keto-PGF 10< elaboration was ob served after only the longest ischemic duration. While TxB2 levels gradually decreased during the 3-h reperfu sion period in all groups, the levels in the group subjected to 8 min of ischemia returned to control values most rap idly. A relationship between the duration of ischemia and
The liberation of arachidonic acid during cerebral ischemia (Bazan, 1970; Gardiner et aI., 1981; Rehn crona et aI., 1982; Goto et aI., 1988; Yoshida et aI., 1986) and its subsequent metabolism by the cyclo oxygenase and lipoxygenase enzyme systems to yield eicosanoids have been demonstrated by sev eral investigators. The effect of eicosanoids on isch emic neuronal injury has been the subject of exten-TxB2 production was therefore evident. 6-Keto-PGFlo< levels increased in only the group subjected to 20 min of ischemia and, by contrast to the pattern of TxB2 change, 6-keto-PGF 10< levels remained elevated throughout the reperfusion period. During reperfusion, the ratio of TxBz to 6-keto-PGF 10< increased substantially versus the pre ischemic period in both structures. The data demonstrate that eicosanoid elaboration following cerebral ischemia can be evaluated by the microdialysis technique. In ad dition, they indicate that the thresholds (duration of isch emia) for the postischemic production and the temporal profiles of TxB2 and 6-keto-PGFlo in the caudate and hippocampus differ. They also demonstrate that there is regional heterogeneity in the patterns of eicosanoid elab oration after forebrain ischemia. Key Words: Cerebral ischemia-Microdialysis-Prostaglandins. sive investigation because eicosanoids have numer ous physiologic effects that might influence the evolution of an ischemic injury. These effects in clude the alteration of platelet function, vascular tone, and vascular permeability (Moncada and Vane, 1979) . In most studies to date, tissue levels of eicosanoids have been measured in brain homoge nates (Gaudet et aI., 1980; Crockard et aI., 1982; Shohami et aI., 1982; Black et aI., 1984; Dempsey et aI., 1986; Dorman, 1988) . This approach has permit ted only a single measurement of eicosanoid levels and has precluded time course determinations in individual animals. Time course determinations of eicosanoid levels were performed by Stevens and Yaksh (Stevens et aI., 1986; Stevens and Yaksh, 1988) . These investigators employed a cerebroven-tricular perfusion technique and demonstrated sub stantial increases in eicosanoid levels in the CSF in the postischemic retlow phase. However, the cere broventricular perfusion technique is limited in that it provides no information as to the anatomic origins of the eicosanoids measured. It is conceivable that the pattern of postischemic eicosanoid concentra tions observed might vary significantly depending upon the specific region of the brain examined.
To achieve temporal and anatomic resolution of the effects of ischemia on eicosanoid formation, we employed the technique of microdialysis to define the structure-specific production of thromboxane (T x)B2 and 6-keto-prostaglandin (6-keto-PG)F Ja in vivo in two of the brain's selectively vulnerable structures, the dorsal hippocampus and the caudate nucleus. The feasibility of using microdialysis to sample eicosanoids in the brain's extracellular space has recently been demonstrated by Yergey and Heyes (1990) . However, the technique has not previously been applied to investigations of cere bral ischemia. In the present study, temporary fore brain ischemia was induced by bilateral carotid ar tery occlusion (BCAO) with simultaneous hypoten sion (Smith et al., 1984) . This approach permitted a comparison of the patterns of TxB2 and 6-keto PGF 1a elaboration over time in two distinct brain regions. In addition, the use of groups subjected to different durations of ischemia (8, 14, or 20 min of BCAO) permitted an evaluation of the dose response relationship of eicosanoid concentration after forebrain ischemia.
MATERIALS AND METHODS
The experimental protocol was approved by the insti tutional animal use subcommittee. Twenty-eight sponta neously hypertensive rats (Harlan Sprague-Dawley, In dianapolis, IN, U.S.A. ) of the same age and weight (275-325 g) were studied. Spontaneously hypertensive rats were utilized because the pattern of injury that is pro duced by forebrain ischemia is more consistent than that which occurs in other strains. As a result, interanimal variability is significantly reduced.
Experimental preparation
After an overnight fast with unlimited access to water, the animals were anesthetized in a Plexiglas box with 4% isoflurane in oxygen. The rats were intubated orotrache ally and mechanical ventilation was instituted with an in spired gas mixture of 2.0% isoflurane in 40% oxygen, balance nitrogen, at a respiratory rate of 60 breaths/min and with a tidal volume of 12 mUkg. The concentration of inspired carbon dioxide was adjusted to maintain normo carbia (PaC02 35-40 mm Hg). Esophageal temperature was servo-controlled to 38°C with an overhead heating lamp. A PE-50 catheter was inserted in the tail artery for continuous measurement of MABP and for intermittent sampling of arterial blood. The right external jugular vein was cannulated with a PE-60 catheter for the manipUla tion of blood volume. Both carotid arteries were exposed and silk sutures were placed around each. At the conclu sion of the surgical preparation, all wounds were infil trated with 0. 25% bupivacaine (Sensorcaine; Astra Phar maceutical Products, Westborough, MA, U.S.A.) and the inspired concentration of isoflurane was reduced to 1.4%. The animals were left undisturbed for an equilibration period of 15 min. Serum glucose, MABP, hematocrit, Paco2, Pao2, and arterial pH were recorded during the equilibration period.
The animals were then placed prone on an elevated platform with the head secured in a stereotaxic frame (David Kopf Instruments, Tujunga, CA, U.S.A.). The tooth bar was positioned 5 mm above the interaural line. The scalp and periosteum were reflected to expose the calvaria and the position of the bregma was marked. With a 1. 2-mm bit, two burr holes were drilled: 2.0 mm caudal and 1.5 mm lateral to the bregma on the right (dorsal hippocampus site); 2. 5 mm rostral and 2.5 mm lateral to the bregma on the left (caudate nucleus site). Two CMA-10 microdialysis probes with 2-mm membrane tips (Bio analytical Systems, West Lafayette, IN, U. S.A. ) were utilized in each experiment. Prior to their insertion, the probes were perfused for a period of 1 h at a rate of 2 I_d/min with mock CSF (126.5 mM NaCI, 27.5 mM NaHC03, 2.4 mM KCI, 0. 5 mM K2HP04, 1.1 mM CaCI2, 0. 85 mM MgCI2, 0.5 mM Na2S04, 5.9 mM glucose, pH 7.5). The microdialysis probes were then mounted on mi cromanipulators and inserted to depths of 7.5 and 5.8 mm (measured from the surface of the skull) into the caudate nucleus and dorsal hippocampus, respectively. The coor dinates for probe insertion were derived from the stereo taxic atlas of the rat brain of Pelligrino et al. (1981) . In preliminary studies, perfusion of the microdialysis probes with Evan's Blue (to mark the location of the probe mem brane in the brain parenchyma) confirmed the reproduc ibility of correct probe placement with the use of the above coordinates.
Experimental protocol
Following an equilibration period of 1.5 h after probe insertion, the animals were randomly allotted to one of four groups (n = 7 for each group). The control group animals were left undisturbed for the duration of the ex periment. The three experimental groups were SUbjected to incomplete forebrain ischemia according to the tech nique of Smith et al. (1984) for intervals of 8 (Group 1), 14 (Group 2), or 20 (Group 3) min. Thirty units of heparin was injected through the right external jugular vein cath eter. Following heparinization, hypotension was induced by the injection of 3 mg of trimethaphan (Arfonad; Roche Laboratories, Nutley, NJ, U.S.A.) intravenously fol lowed by adjustment of intravascular volume to achieve an MABP of 50 mm Hg. Both carotid arteries were oc cluded with vascular clamps for intervals of 8, 14, or 20 min. MABP was maintained at 50 mm Hg either by with drawal of blood from the external jugular vein catheter into a prewarmed syringe or by the reinfusion of with drawn blood. At the conclusion of the ischemic interval, the vascular clamps were removed and reperfusion of the brain was established. Blood pressure was restored by rapid reinfusion of the withdrawn blood. Heparinization was revered by the intravenous administration of 0. 3 mg of protamine sulfate (QUAD Pharmaceuticals, Indianap olis, IN, U.S.A.) and 0.25 mEq of NaHC03 was admin-istered via the arterial catheter for correction of metabolic acidosis. During the reperfusion period, MABP was maintained above 110 mm Hg by infusion of normal sa line, 2.5 mllkg, as necessary. Three hours after reperfu sion was established, the experiment was terminated and the animals were killed.
Microdialysis
Collection of microdialysis effluent began immediately after probe insertion and continued for the duration of the experiment. The probes were perfused with mock CSF at a rate of 2 J.,LI/min and the dialysate was collected in 30min epochs for 1.5 h during the preis chemic interval and for 3 h during reperfusion. During the ischemic interval, dialysate was collected for 8, 14, or 20 min, depending upon the duration of BCAO. The samples were frozen at -20°C for later analysis.
Eicosanoid analysis
The dialysate from each 30-min epoch (�60 J.LI per structure) was divided into two equal aliquots, one for the measurement of TxB2 and the other for the measurement of 6-keto-PGFla. TxB2 and 6-keto-PGFla levels in the dialysate were measured by radioimmunoassay using commercially available antisera (Advanced Magnetics, Cambridge, MA, U.S.A.). According to the manufac turer, the rabbit anti-TxB2 in the kit is highly specific for TxB2 with cross reactivities to other PGs of the A, B, E, D, and F series and their metabolites being <0.1 %. Rab bit anti-6-keto-PGF la has cross reactivities to PGF la ' 6-keto-PGEI, PGF2a, PGEI, and PGE2 of 7.8,6.8, 2.2, 0.7, and 0.6%, respectively. Cross reactivity to other PGs of the A, B, and D series and their metabolites is <0.01%.
Eicosanoid recovery
The percentage recovery of TxB2 and 6-keto-PGFla by the CMA-lO microdialysis probes used in this study was determined in vitro. The technique was identical for TxB2 and 6-keto-PGFla. For TxB2, the microdialysis probes were placed in solutions (in saline) of tritiated TxB2 (Ad vanced Magnetics) in concentrations of 16.7 and 3.4 ng/ m!. These concentrations were chosen to span the range of estimated in vivo concentrations based on preliminary studies and an a priori estimate of 10% recovery. The relative concentrations of the tritiated TxB2 in the stock solutions and in the microdialysis samples were deter mined by liquid scintillation counting and the percentage recovery of TxB2 was calculated. In vitro recovery of 6-keto-PGFla was determined in the same manner using solutions of 16.7 and 3.4 ng/m!.
Statistical analysis
The physiologic data were assessed by analysis of vari ance with Scheffe's test for multiple comparisons. A pre liminary evaluation of the eicosanoid levels in the dialy sate had suggested that the data were not normally distributed. Accordingly, they were subjected to a good ness-of-fit testing of normality and were found not to be normally distributed. The data were therefore analyzed with the Kruskal-Wallis test with Dunn's test for multiple comparisons (Zar, 1984) . A p value of <0.05 was consid ered statistically significant.
RESULTS
Twenty-eight spontaneously hypertensive rats were studied. The dialysate from three animals, one in each of the ischemic groups, was discarded be cause of technical problems with the microdialysis catheters. The weights of the animals in the control and ischemic groups were not different.
The in vitro recovery of TxB2 and 6-keto-PGF 10: was independent of their respective concentrations in the stock solutions. The recovery of TxB2 from the high and low concentration stock solutions was 5.5 ± 1. 0 and 6. 1 ± 1. 0%, respectively. The recov ery of 6-keto-PGF 10: from the high and low concen tration stock solutions was 5.5 ± 0. 7 and 6.9 ± 0. 3%, respectively.
The physiologic data, measured immediately prior to BCAO, are presented in Table I . Heart rate, MABP, Paco2, pH, and serum glucose were not different among the four groups. P a02 was slightly greater in Group 2 (14 min of BCAO) than in the other three groups.
Penetration of the brain by the microdialysis probes resulted in increased recovery of TxB2 and 6-keto-PGF 10:' However, the concentration of these eicosanoids stabilized 1 h after probe insertion and in control animals remained unchanged for the du ration of the experiment (Fig. 1 ). The eicosanoid concentrations in the dialysate during the third 30min epoch (immediately preischemia) were taken as baseline values. For clarity of presentation, the data from the first hour of microdialysis are not presented in the subsequent figures.
Caudate nucleus
TxB2 concentrations in the dialysate at baseline, during ischemia, and during reperfusion are shown in Fig. 2 (left) . At baseline, the TxB2 levels did not differ among the groups. During the ischemic inter val (8, 14, or 20 min of BeAO), TxB2 levels re mained unchanged. In the initial reperfusion period, Caudate Nucleus 2500 * the levels of TxB2 increased significantly in all three ischemic groups, reaching peak values of 1,386 ± 235, 1,352 ± 239, and 1,547 ± 314 pg/ml in the di alysate in the 8-, 14-, and 20-min ischemia groups, respectively. In the 8-min ischemia group, the TxB2 levels returned to control group values after 2 h of reperfusion. In contrast, the TxB2 levels in the 14and 20-min ischemia groups, although declining during the reperfusion period, remained greater than control group values to the end of the 3-h pe riod of reperfusion .
The time course of the changes in 6-keto-PGFJ()[ concentrations in the dialysate is shown in Fig. 3  (left) . At baseline, 6-keto-PGF J()[ levels were similar in all groups. During the ischemic interval, the 6-keto-PGFJ()[ level in the 20-min ischemia group in creased slightly. With reperfusion, the 6-keto PGF J()[ levels in the 20-min ischemia groups in creased significantly, reaching a peak level of 348 ± 39 pg/ml. The 6-keto-PGF J()[ levels remained ele vated throughout the reperfusion period in the 20min ischemia group. The 6-keto-PGFJ()[ levels in the 8-and 14-min ischemia groups did not increase dur ing reperfusion and were not different from those of the control group.
Dorsal hippocampus
The time course of changes in the concentrations of TxB2 in the hippocampal dialysate is shown in Fig. 2 (right) . Baseline concentrations of TxB2 in the 20-min ischemia group was statistically greater than that in the 8-min ischemia group, although the difference was small. During the ischemic interval, levels of TxB2 remained unchanged. With reperfu sion, TxB2 concentration increased significantly above control values in all three ischemic groups, reaching peak values of 508 ± 130, 519 ± 92, and 670 ± 80 pg/ml in the 8-, 14-, and 20-min ischemia groups, respectively. Peak TxB2 levels were similar in all ischemic groups. However, the decrease in TxB2 concentration during reperfusion was more rapid in the 8-min ischemia group, reaching control values after 1.5 h of reperfusion. In contrast, TxB2 levels in the 14-and 20-min ischemia groups reached control levels 2.5 and 3 h, respectively, af ter reperfusion was established. Figure 3 (right) presents the changes in the con centration of 6-keto-PGF 10< in the hippocampal di alysate over time. Baseline concentrations were similar in all groups. With ischemia and subsequent reperfusion, the 6-keto-PGF 10< concentration in the 20-min group increased significantly (peak level 680 ± 85 pg/ml). The levels decreased gradually during reperfusion, but remained significantly above con trol levels at the conclusion of the 3-h reperfusion period. In contrast, the 6-keto-PGFlo< levels in the 8-and 14-min ischemia groups remained unchanged and were not different from the control group val ues at any interval.
Although the temporal patterns of the elaboration of TxB2 and 6-keto-PGFlo< in the caudate nucleus and dorsal hippocampus were similar, the absolute amounts of these eicosanoids in the dialysate dif-J Cereb Blood Flow Metab, Vol. 12, No.1, 1992 fered in the two structures. Peak concentrations of TxB2 were greater in the caudate than in the dorsal hippocampus (1,386 ± 235 vs. 508 ± 130, 1,352 ± 239 vs. 519 ± 92, and 1,547 ± 314 vs. 670 ± 80 pg/ml in the 8-, 14-, and 20-min ischemia groups, respec tively). By contrast, peak concentrations of 6-keto PGF 10< were greater in the dorsal hippocampus than in the caudate (680 ± 85 vs. 348 ± 39 pg/ml in the 20-min ischemia group, respectively). The ratios of the concentrations of TxB2 and 6-keto-PGFlo< in the caudate nucleus and dorsal hippocampus were both <1.0 (0.4 and 0.7, respectively). After 30 min of reperfusion, the ratios of TxB2 to 6-keto-PGF I", had increased to values > 1.0 in both structures. How ever, because of the greater concentrations of TxB2 in caudate dialysate, the TxB2/6-keto-PGF I", ratios in the caudate were greater than those in the dorsal hippocampus (15.9 vs. 2.6, 8.4 vs. 2.0, and 5.1 vs. 1.0 in the 8-, 14-, and 20-min ischemia groups, re spectively).
DISCUSSION
There are considerable data that demonstrate the increased production of eicosanoids in the postisch emic brain (Gaudet et al., 1980; Shohami et aI, 1982; Black et aI., 1984; Dempsey et aI., 1986; Dorman, 1988) . The increased levels of eicosanoids have usu ally been measured in brain homogenates, but re gional, structure-specific evaluations of eicosanoid production have not been performed previously. It is clear that the brain is inhomogeneous in its re sponse to ischemia, with some structures being more vulnerable to ischemic injury than others (Pulsinelli and Brierley, 1979) . This study was therefore undertaken to evaluate the production of TxB2 and 6-keto-PGF la (stable metabolites of TxA2 and prostacyclin, respectively) in two of the selec tively vulnerable regions of the brain, the caudate nucleus and dorsal hippocampus. The data demon strate that TxB2 and 6-keto-PGFla are produced during the reperfusion phase following ischemia, confirming the results obtained by other investiga tors (Gaudet et aI., 1980; Shohami et aI., 1982; Black et aI., 1984; Dempsey et aI., 1986; Dorman, 1988) . Elevated levels of TxB2 were seen with all three durations of ischemia, whereas increased lev els of 6-keto-PGF la were detected in only the group subjected to the longest period (20 min) of forebrain ischemia. While the temporal profiles of eicosanoid generation in the two structures studied were qual itatively similar, there were quantitative differences that indicate the occurrence of structure-specific differences in postischemic eicosanoid production. In addition, the data indicate the occurrence of a relative excess of TxB2 as compared to 6-keto PGF la in both structures.
The recovery of TxB2 from the caudate nucleus and the dorsal hippocampus differed. Upon reper fusion, TxB2 levels increased markedly in the cau date. These data are consistent with the similar postischemic elevations in TxB2 levels that have been demonstrated in brain homogenates (Gaudet et aI., 1980; Shohami et aI., 1982; Black et aI., 1984; Dempsey et aI., 1986; Dorman, 1988) and in CSF (Stevens and Yaksh, 1988) . Peak levels of TxB2 were similar in all three ischemic groups. Thus, in this study, the threshold for production of TxB2 was 8 min of BCAO (and, in fact, may be lower). The decline in TxB2 levels during reperfusion was more rapid with 8 min than with 14 or 20 min of BCAO in both structures. In the 8-min group, TxB2 concen trations fell to levels comparable with those of the nonischemic control group after 2 h of reperfusion, while those in the 14-and 20-min groups were ele vated for the duration of the study. The persistent elevation in the latter groups may reflect either greater TxB2 production or a reduced rate of TxB2 clearance after longer periods of ischemia. The data do not permit differentiation of those two possibil ities. While the temporal profile of TxB2 elaboration in the dorsal hippocampus was qualitatively similar to that in the caudate nucleus, the peak levels of TxB2 in the caudate (1,352 ± 239 to 1,547 ± 314 pg/ml) were considerably greater than those in the dorsal hippocampus (508 ± 130 to 670 ± 80 pg/ml).
The reason for the greater TxB2 production in the caudate is not clear. Greater substrate (arachido nate) availability in the caudate or perhaps differing affinities of enzyme systems for the substrate in these two structures may play a role. There is an additional observation that may be of relevance. TxB2 levels following 14 min of ischemia were sim ilar to those after 20 min of ischemia in both struc tures. This suggests that the capacity of cerebral tissue to produce TxB2 may be limited (a plateau effect).
The recovery of 6-keto-PGF la in dialysate dif fered markedly from that of TxB2. Increased 6-keto PGF la levels were evident only in the group sub jected to 20 min of ischemia. Once increased, 6-keto-PGFla levels remained elevated throughout the reperfusion period. Therefore, a more severe ischemic insult was required to result in increased concentrations of 6-keto-PGFla (20 min of BCAO) than of TxB2 (8 min of BCAO). A possible expla nation for this observation may lie in differences in the cells of origin of these two eicosanoids. Brain parenchyma (neurons and glia) can synthesize TxB2 (Wolfe et aI., 1976) . By contrast, the majority of 6-keto-PGFla measured in the brain is of vascular origin (Abdel-Halim et aI., 1980a,b) , with little con tribution by the glia and neurons (Keller et aI., 1985; Seregi et aI., 1987; Hertting and Seregi, 1989) . Therefore, for 6-keto-PGFla to be detected in the dialysate, it must first diffuse from its site of pro duction (cerebral vessels) to the extracellular fluid space of the brain. It is conceivable that this diffu sion may require or at least be significantly facili tated by a breakdown of the blood-brain barrier (BBB). As damage to the BBB following ischemia and reperfusion is related to the severity of isch emia (Todd et aI., 1986) , the greater damage to the BBB following 20 min of forebrain ischemia may have been necessary for significant diffusion of 6-keto-PGFla to the extracellular fluid space to oc cur. Increased 6-keto-PGF la concentrations have been observed by others in association with shorter durations of ischemia (2.5-15 min) (Gaudet et aI., 1980; Shohami et aI., 1982; Black et aI., 1984; Dempsey et aI., 1986; Dorman, 1988; Tegtmeier et aI., 1990) . However, in these investigations, PG lev els were measured in brain homogenates. In brain homogenates, the PGs detected may have arisen not only from neural tissue but also from cerebral microvessels.
While the absolute levels of TxB2 and 6-keto PGF la produced are relevant, it may be that it is the ratio of TxB2 to 6-keto-PGFla that is more impor tant physiologically. It has been proposed that an imbalance in the concentrations of these ei-cosanoids (resulting in a relative excess of TxB2) would tend to enhance vasoconstriction and platelet aggregation (Stevens et aI., 1986; Galli et al., 1989) . Although the TxB2/6-keto-PGFlo: ratio increased in the postischemic period in both structures, the ratio was much greater, i.e., more "unfavorable," in the caudate than in the hippocampus. If this ratio were important pathophysiologic ally , then it might be predicted that the caudate would be the more sus ceptible to ischemic damage. While both structures are among those considered to be selectively vul nerable, it is the hippocampus that is generally viewed as the more sensitive. Accordingly, addi tional factors must also contribute to the evolution of the postischemic insult.
It may be noteworthy that the TxB2/6-keto PGFlo: ratios in both the caudate and the hippocam pus were highest following 8 min of BCAO (15.9 and 2.4, respectively). In spontaneously hyperten sive rats in our laboratory, 8 min of BCAO is below the threshold for the occurrence of a detectable gross motor neurologic deficit. The 8-min insult is associated with a moderately severe yet incomplete (70-90% cell loss) injury to the CAl area bilaterally with little damage to other brain regions. Longer periods of forebrain ischemia ( > 10 min) invariably result in complete histologic destruction of the CAl sector of the hippocampus, with damage also evi dent in other areas (unpublished observations). Thus, in the model employed in the present study, the TxB2/6-keto-PGF 10: ratio is greatest with a near threshold insult and is less dramatically increased with ischemic durations that produce devastating neurologic injury. This raises the possibility that the TxB2/6-keto-PGF 10: ratio is most relevant in the set ting of the threshold ischemic insult.
The present observations regarding postischemic increases in TxB2/6-keto-PG F 10: ratios are consis tent with several previous demonstrations that in terventions intended to decrease postischemic Tx production attenuate the sequelae of ischemia. Sup pression of TxB2 production, either by cyclooxy genase or Tx synthase inhibition, has been shown to improve postischemic cerebral blood flow (Black et aI., 1984; Stevens et aI., 1986; Kochanek et aI., 1988; Pettigrew et aI., 1989) and to reduce neuronal death in the CAl sector of the hippocampus (Naka gomi et aI., 1989; Sasaki et aI., 1989) . Similarly, prostacyclin and its analogues have been shown to improve postischemic cerebral blood flow (Masuda et aI., 1986) and to reduce postischemic memory deficit (Borzeix et aI., 1988) . The available data are therefore consistent with the notion that interven tions that reduce Tx formation relative to that of prostacyclin attenuate ischemic neuronal injury.
J Cereb Blood Flow Metab, Vol. 12. No. I, 1992 In the present study, core body temperature was measured by a probe inserted into the distal esoph agus. However, it has been demonstrated that body temperature does not correlate with brain tempera ture during episodes of cerebral ischemia (Busto et aI., 1987; Minamisawa et aI., 1990) . It is therefore possible that the brain temperature in the animals rendered ischemic in the present study was less than the esophageal temperature, especially during the interval of forebrain ischemia. Accordingly, the present results may represent an underestimate of prostanoid production in the postischemic brain. However, within each group, this temperature dis crepancy was probably comparable and the com parison of the relative formation of TxB2 and 6-keto-PGF 10: should be valid.
In conclusion, our data show that, f'ollowing fore brain ischemia, TxB2 and 6-keto-PGFlo: are present in increased concentrations in both the caudate nu cleus and the dorsal hippocampus. However, the data demonstrate regional heterogeneity in post ischemic eicosanoid production in the brain. TxB2 concentrations were greater in the caudate nucleus than in the hippocampus, while 6-keto-PGFlo: con centrations were greater in the hippocampus than in the caudate nucleus. The data also indicate that the threshold (minimum requisite duration of ischemia) for the occurrence of increased concentrations of TxB2 and 6-keto-PGFlo: differed. While increased concentrations of TxB2 were observed in both structures after 8 min of forebrain ischemia, in creased levels of 6-keto-PGF 10: were detected only after a 20-min ischemic insult. TxB2 recovery was greater than that of 6-keto-PGF 10: in both struc tures, thereby resulting in an increased ratio of TxB2 to 6-keto-PGF 10:' This latter observation is consistent with a role of an imbalance in TxB2 and 6-keto-PGF 10: concentrations in the pathophysiol ogy of ischemic neuronal injury in these structures. Finally, this demonstration of the occurrence of re gional differences in the cerebral response to isch emia highlights the importance of region-selective analysis in investigations of the pharmacology and biochemistry of cerebral ischemia.
